LifeScience Clinical & Diagnostic
Europe Approves TEPKINLY Combination as First Bispecific-Based Second-Line Therapy for Follicular Lymphoma
TEPKINLY® (epcoritamab) plus lenalidomide and rituximab (R2) is the first and only bispecific-based therapy approved in Euro...
July 08, 2026 | News
Ascletis Files Dual US INDs for Ultra-Long-Acting Obesity Therapies Targeting Amylin, GLP-1 and GIP Receptors
ASC36_35 FDC, a once-monthly subcutaneous (SQ) injection co-formulation of ASC36 and ASC35, is a potentially first-in-class drug candidate targeting thre...
July 07, 2026 | News
Arima Genomics Partners with Active Motif to Expand Global Access to Hi-C Research Portfolio
Agreement Part of Arima’s Long-Term Strategy to Focus on Core Diagnostic Platform and Tests Arima Genomics, Inc., a cancer diagnostics com...
July 07, 2026 | News
Abu Dhabi DoH and MIT Koch Institute Partner to Advance AI-Enabled Oncology Research
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, and the MIT – Koch Institute for Integrative...
July 06, 2026 | News
Abbisko and AstraZeneca Partner to Advance Novel Oral IO-TKI Combination for EGFR-Mutant Lung Cancer
Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter, announced that it has entered into a strategic collaboration agreement with AstraZeneca (...
July 03, 2026 | News
Colossal Foundation and University of Tasmania Partner to Fight Deadly Tasmanian Devil Cancer with Gene Editing and Vaccines
The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer...
July 01, 2026 | News
Innovent and Lilly Expand China Oncology Partnership with Verzenios Commercialisation Agreement
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality m...
July 01, 2026 | News
CanSinoBIO Secures Argentina Approval for Menhycia Quadrivalent Meningococcal Conjugate Vaccine
CanSino Biologics Inc. (SSE: 688185, HKEX: 06185) announced that the Company's ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) (the "MCV4",...
July 01, 2026 | News
Anivive Wins Full U.S. FDA Approval for Laverdia, First At-Home Oral Treatment for Canine Lymphoma
Anivive converts Laverdia-CA1 to full FDA approval First FDA-approved product to validate Anivive's AI-enabled development model &md...
June 30, 2026 | News
Everest Medicines' LEROCHOL® BLA Accepted in China for Third-Generation PCSK9 Inhibitor
Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...
June 29, 2026 | News
S-CELL Launches Next-Generation Synbiotic to Naturally Support GLP-1 Production for Metabolic Health
S-CELL, a premier innovator in cellular health and anti-aging biotechnology, today announced the launch of its advanced metabolic support synbiotic (Prebio...
June 29, 2026 | News
HKeyBio Launches NHP Fast-Tox Program to Accelerate Early Safety Assessment for Biologics
The program supports early tolerability assessment, PK/TK-linked safety evaluation, immune-related risk screening, and pre-GLP dose design for biologics an...
June 26, 2026 | News
Waters and IMU Biosciences Partner to Advance AI-Powered High-Definition Immune Profiling
MU's AI platform unlocks unprecedented immune insights for cancer and other diseases, measuring 100M+ data points from a single blood sample, analyze...
June 26, 2026 | News
Metabolon Delivers Landmark Metabolomics Dataset to Advance Rare Disease Research with Genomics England
Metabolon, Inc., the global leader in metabolomics solutions advancing life science research, diagnostics, therapeutics, and precision medicine, announced ...
June 26, 2026 | News
Most Read
- How Does GLP-1 Work?
- Innovations In Magnetic Resonance Imaging Introduced By United Imaging
- Management of Relapsed/Refractory Multiple Myeloma
- 2025 Drug Approvals, Decoded: What Every Biopharma Leader Needs to Know
- BioPharma Manufacturing Resilience: Lessons From Capacity Expansion and Supply Chain Resets from 2025
- APAC Biopharma Review 2025: Innovation, Investment, and Influence on the Global Stage
- Top 25 Biotech Innovations Redefining Health And Planet In 2025
- The New AI Gold Rush: Western Pharma’s Billion-Dollar Bet on Chinese Biotech
- Single-Use Systems Are Rewiring Biopharma Manufacturing
- The State of Biotech and Life Science Jobs in Asia Pacific – 2025
- Asia-Pacific Leads the Charge: Latest Global BioSupplier Technologies of 2025
- Invisible Threats, Visible Risks: How the Nitrosamine Crisis Reshaped Asia’s Pharmaceutical Quality Landscape
Bio Jobs
- Sanofi Turns The Page As Belén Garijo Steps In And Paul Hudson Steps Out
- Global Survey Reveals Nearly 40% of Employees Facing Fertility Challenges Consider Leaving Their Jobs
- BioMed X and AbbVie Begin Global Search for Bold Neuroscience Talent To Decode the Biology of Anhedonia
- Thermo Fisher Expands Bengaluru R&D Centre to Advance Antibody Innovation and Strengthen India’s Life Sciences Ecosystem
- Accord Plasma (Intas Group) Acquires Prothya Biosolutions to Expand Global Plasma Capabilities
- ACG Announces $200 Million Investment to Establish First U.S. Capsule Manufacturing Facility in Atlanta
- AstraZeneca Invests $4.5 Billion to Build Advanced Manufacturing Facility in Virginia, Expanding U.S. Medicine Production
News
Editor Picks
